about
MED12 controls the response to multiple cancer drugs through regulation of TGF-β receptor signalingUnresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR.Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma.Intrinsic resistance to MEK inhibition in KRAS mutant lung and colon cancer through transcriptional induction of ERBB3.RAF suppression synergizes with MEK inhibition in KRAS mutant cancer cells.Feedback and redundancy in receptor tyrosine kinase signaling: relevance to cancer therapies.SMARCE1 suppresses EGFR expression and controls responses to MET and ALK inhibitors in lung cancer.
P50
Q24304423-44B91998-1792-4386-82B0-D5D51A91B32EQ27851711-7AD8068C-6F77-4DD4-8229-9D1DD7A270C9Q27852990-3F0238BD-49A3-46B2-80E6-3F02C2642BD7Q27852991-1F60FB5E-A875-42F5-82A0-F82B643E861CQ27853064-38E43CAD-7F77-4D46-BB06-DC6012D9EECEQ38252687-FFC3EBF8-DB88-438E-BC6E-EE7F9BE90EDDQ38912433-7EA22227-C99C-475F-BFFE-C96FA6CB26FA
P50
description
researcher
@en
հետազոտող
@hy
name
Chong Sun
@ast
Chong Sun
@en
Chong Sun
@es
Chong Sun
@nl
Chong Sun
@sl
type
label
Chong Sun
@ast
Chong Sun
@en
Chong Sun
@es
Chong Sun
@nl
Chong Sun
@sl
prefLabel
Chong Sun
@ast
Chong Sun
@en
Chong Sun
@es
Chong Sun
@nl
Chong Sun
@sl
P106
P31
P496
0000-0001-9008-2158